MoneyWorks4Me

Vasundhara Rasayans - Quaterly Results

28 May 2024 Evaluate
The Revenue for the quarter ended  March 2024 of Rs. 111.39 millions grew by 12.37 % from Rs. 99.13 millions.The Net Profit of the company reported a remarkable increase of 398.36% to Rs. 21.33  millions  from Rs. 4.28 millions in previous same quarter.Operating Profit saw a handsome growth to 30.13 millions from 7.36 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 111.39 99.13 12.37 370.18 379.41 -2.43 370.18 379.41 -2.43
Other Income 7.44 1.67 345.51 19.41 22.98 -15.54 19.41 22.98 -15.54
PBIDT 30.13 7.36 309.38 83.33 78.06 6.75 83.33 78.06 6.75
Interest 0.80 0.37 116.22 2.64 1.31 101.53 2.64 1.31 101.53
PBDT 29.33 6.99 319.60 80.69 76.75 5.13 80.69 76.75 5.13
Depreciation 0.74 2.00 -63.00 1.74 2.00 -13.00 1.74 2.00 -13.00
PBT 28.59 4.99 472.95 78.95 74.75 5.62 78.95 74.75 5.62
TAX 7.26 0.71 922.54 20.36 18.85 8.01 20.36 18.85 8.01
Deferred Tax 0.48 -0.02 -2500.00 0.48 -0.02 -2500.00 0.48 -0.02 -2500.00
PAT 21.33 4.28 398.36 58.59 55.90 4.81 58.59 55.90 4.81
Equity 31.78 31.78 0.00 31.78 31.78 0.00 31.78 31.78 0.00
PBIDTM(%) 27.05 7.42 264.32 22.51 20.57 9.41 22.51 20.57 9.41
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..